Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Rojek JM, Kunz S
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) target the underlying biology of weight gain
If you require injectable vitamin B12, your doctor will advise on the dosage
The critical unknowns include: Cardiovascular Safety: The glucagon component requires independent, long-term evaluation in populations with a high risk of heart disease
Embracing smaller, nutrient-dense portions from day one will help you maximize the weight-loss benefits of the medication while keeping your energy levels stable
Tirzepatide (sold as Mounjaro and Zepbound) is FDA approved and available now, while Retatrutide remains in Phase 3 trials with expected approval sometime between 2026 and 2027
